1. Home
  2. STRT vs RCKT Comparison

STRT vs RCKT Comparison

Compare STRT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

HOLD

Current Price

$78.36

Market Cap

345.3M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.76

Market Cap

401.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRT
RCKT
Founded
1908
1999
Country
United States
United States
Employees
N/A
202
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
345.3M
401.6M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
STRT
RCKT
Price
$78.36
$3.76
Analyst Decision
Hold
Buy
Analyst Count
1
14
Target Price
$93.00
$29.73
AVG Volume (30 Days)
78.5K
3.0M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
12.53
N/A
EPS
4.04
N/A
Revenue
$439,195,000.00
N/A
Revenue This Year
$4.22
N/A
Revenue Next Year
$2.04
$64.28
P/E Ratio
$19.27
N/A
Revenue Growth
5.24
N/A
52 Week Low
$57.01
$2.53
52 Week High
$92.50
$5.45

Technical Indicators

Market Signals
Indicator
STRT
RCKT
Relative Strength Index (RSI) 47.87 70.84
Support Level $77.01 $3.32
Resistance Level $84.20 $4.04
Average True Range (ATR) 3.42 0.22
MACD -0.14 0.09
Stochastic Oscillator 9.83 99.16

Price Performance

Historical Comparison
STRT
RCKT

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: